Company
AusMed Global Limited (AusMed) was founded in late 2017. AusMed headquartered in the Hong Kong Science Park is a fast-growing biotech company focusing on providing affordable non-invasive medical devices and solutions for both home and point-of-care uses in response to the global challenges in diabetes, overweight and obesity.
AusMed is the industrial partner of the University of Sydney and a game changer in ketone measurement innovation. Its patented “Non-invasive Photonic Sensing for Monitoring Diabetes” makes AusMed the industry pioneer in providing a truly non-invasive handheld breath ketone analyser with both high Accuracy & high Selectivity. One breath with a result in 3 min provides an unprecedented experience in diabetic ketoacidosis (DKA) management and ketosis monitoring for weight loss and diet management. The smart-diet app with the cloud-based AI expert system for diet management enables remote patient monitoring and big data analytics of chronic disease risk assessment for the betterment of public health.
AusMed obtained approval for conducting clinical studies in Hong Kong and is preparing for clinical trials and regulatory approval in numerous countries. AusMed obtained the Judges’ Recognition Award of the HKABA NSW Chapter Business Awards 2021; and the Silver Medal from 2022 Geneva International Exhibition of Inventions for its invention “KetoMetrics – High-Performance Fat Loss Management Solution”.
